November 18th 2024
More than half of US adults—approximately 137 million—are candidates for semaglutide based on diabetes, weight management, or cardiovascular prevention indications.
November 16th 2024
Late Night Meals Bad for Blood Sugar Control and Weight Loss
June 12th 2020A study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism has found that eating a late may be a contributing factor to weight gain and hyperglycemia -- factors that may also exaccerbate heart disease.
New Guidance for Treating Diabetic COVID-19 Patients in the ICU
June 10th 2020According to the report, more than 20 percent of COVID patients in the ICU are patients with diabetes, presenting challenges for the clinicians managing their care. Diabetic patients with COVID-19 in the ICU need both complex medical management of their COVID disease, along with blood sugar control to minimize complications and mortality risk- and that can require multiple patient interactions that put the provider at risk.
Glucose Management of COVID-19 Patients in the ICU Gets New Provider Guidelines
June 10th 2020According to the report, more than 20 percent of COVID patients in the ICU are patients with diabetes, presenting challenges for the clinicians managing their care. Diabetic patients with COVID-19 in the ICU need both complex medical management of their COVID disease, along with blood sugar control to minimize complications and mortality risk- and that can require multiple patient interactions that put the provider at risk.
Ticagrelor Now For Use in Diabetic Patients Without History of MI or Stroke Says FDA
June 2nd 2020The oral antiplatelet drug Ticagrelor (Brilinta, Astra Zeneca), was approved this week by the US Food and Drug Administration (FDA) for use in patients with coronary artery disease (CAD) who are at high risk for a first heart attack or stroke. The change adds new treatment options to diabetic pateints at high risk for cardiac events.
FDA Expands Use of Ticagrelor to Patients Without History of MI or Stroke
June 2nd 2020The oral antiplatelet drug Ticagrelor (Brilinta, Astra Zeneca), was approved this week by the US Food and Drug Administration (FDA) for use in patients with coronary artery disease (CAD) who are at high risk for a first heart attack or stroke.
Simple Blood Test Could Predict Risk of Type 2 Diabetes
May 25th 2020Scientists have discovered metabolites in the blood that accurately predict whether a woman who has experienced gestational diabetes during pregnancy will go on to develop type 2 diabetes (T2D) later. The researchers believe that this simple test could lead to early diagnosis of woman at risk, and interventional treatment.
Two Decade Long Study Shows Decline in Cardiovascular Disease Among Diabetics
April 30th 2020Australian researchers have new evidence that patients with diabetes have fewer cardiovascular events today than they did 20 years ago. The data came from an analysis of the Freemantle diabetes study which compared people with type 2 diabetes to people without diabetes. The results were recently published in the Journal of Clinical Endocrinology and Metabolism.
Sleep Apnea Linked to High Blood Sugar in African-Americans
April 28th 2020According to a new study published in the Journal of the American Heart Association, African Americans with sleep disturbances are much more likely to experience changes in glucose metabolism which could predispose them to diabetes.
Diabetes Cured in Lab Mice Using CRISPR Gene Editing
April 27th 2020It's the ultimate goal for diabetes researchers: restoring the lost insulin producing function of the islet cells of the pancreas. And finally, researchers at Washington University School of Medicine in St. Louis, may be one step closer to realizing that dream.